Patents by Inventor June K. Wu

June K. Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240366641
    Abstract: Provided herein are methods and compositions for treating and preventing vascular malformations including lymphatic, venous, capillary, arteriovenous, and combinations thereof. Methods of treatment and prevention include the administration of proteasome inhibitors, omipalisib, disulfiram, and agents which target genes in the PI3K/AKT/mTOR or RAS/RAF/MAPK pathways, including but not limited to Pik3ca, Pik3r3, Tsc2, Rasa1, Map2k2, and Glmn.
    Type: Application
    Filed: July 15, 2024
    Publication date: November 7, 2024
    Applicant: The Trustees of Columbia University in the City of New York
    Inventors: Carrie J. SHAWBER, June K. WU, Ajit MULEY
  • Patent number: 12070468
    Abstract: Provided herein are methods and compositions for treating and preventing vascular malformations including lymphatic, venous, capillary, arteriovenous, and combinations thereof. Methods of treatment and prevention include the administration of proteasome inhibitors, omipalisib, disulfiram, and agents which target genes in the PI3K/AKT/mTOR or RAS/RAF/MAPK pathways, including but not limited to Pik3ca, Pik3r3, Tsc2, Rasa1, Map2k2, and Glmn.
    Type: Grant
    Filed: November 10, 2022
    Date of Patent: August 27, 2024
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Carrie J. Shawber, June K. Wu, Ajit Muley
  • Publication number: 20230141664
    Abstract: Provided herein are methods and compositions for treating and preventing vascular malformations including lymphatic, venous, capillary, arteriovenous, and combinations thereof. Methods of treatment and prevention include the administration of proteasome inhibitors, omipalisib, disulfiram, and agents which target genes in the PI3K/AKT/mTOR or RAS/RAF/MAPK pathways, including but not limited to Pik3ca, Pik3r3, Tsc2, Rasa1, Map2k2, and Glmn.
    Type: Application
    Filed: November 10, 2022
    Publication date: May 11, 2023
    Inventors: Carrie J. Shawber, June K. Wu, Ajit Muley